Response Evaluation Criteria in Solid Tumors Version 1.0

Known as: RECIST 1.0 
A standardized guideline developed by the Response Evaluation Criteria in Solid Tumors (RECIST) Working Group in 2000, which is an objective response… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Immunotherapy with high-dose interleukin-2 (HD-IL2) results in long-term survival in some metastatic renal cell… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2015
2015
BACKGROUND & AIMS To compare selective internal radiation therapy (SIRT) with transarterial chemoembolization (TACE), the… (More)
Is this relevant?
2015
2015
OBJECTIVE. Response Evaluation Criteria in Solid Tumors (RECIST) is the most widely accepted method to objectively assess… (More)
Is this relevant?
2014
2014
We compared morphologic computed tomography (CT)-based to metabolic fluoro-deoxy-glucose (FDG) positron emission tomography (PET… (More)
  • table 2
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2014
2014
PURPOSE To compare performance of various tumour response criteria (TRCs) in assessment of regorafenib activity in patients with… (More)
Is this relevant?
2013
2013
OBJECTIVE To compare the diagnostic performance in evaluating the response of neoadjuvant chemotherapy (NAC), between the… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2013
2013
OBJECTIVE Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 has been rapidly accepted in clinical trials as a standard… (More)
Is this relevant?
2012
2012
Individual cases of prolonged complete response (CR) of HER2-positive metastatic breast cancer (MBC) have been reported following… (More)
  • table 1
  • table 1
Is this relevant?
2012
2012
BACKGROUND Vinflunine (VFL) has been approved in the European Union for second-line treatment of advanced transitional cell… (More)
Is this relevant?
2011
2011
Improvements in radiologic imaging technology and therapeutic options available for management of tumors have necessitated the… (More)
  • figure 1
  • figure 2
  • figure 5
  • figure 4
  • figure 6
Is this relevant?